Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1CNS 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Pain 1Mucositis 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1

Interventions

Cisplatin 52Radiotherapy 43Cetuximab 30Fluorouracil 27pembrolizumab 19Carboplatin 19Docetaxel 14Paclitaxel 8Radiotherapy, Intensity-Modulated 7Nivolumab 6Methotrexate 6Drug Therapy 6Surgical Procedures, Operative 5Chemotherapy, Adjuvant 5Radiation 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4nimotuzumab 3Taxes 3Chemoradiotherapy 3toripalimab 2lenvatinib 2epacadostat 2durvalumab 2dehydroftorafur 2camrelizumab 2avelumab 2advexin 2Specimen Handling 2Radiotherapy, Conformal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Squamous Cell Carcinoma of Head and Neck × Doxepin × Clear all
NCT01156142 2017-08-09

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
155 enrolled 12 charts
CNSHead & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Pain, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡